NR4A1 and neoplasm: To determine whether NR4A1 can reduce migration in tumour cells, the breast tumour cell lines PMC42, ZR-75-1 and MDA-MB-231 ectopically expressing NR4A1 (Figure 4a) were used in transwell migration assays.